Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Several foveal variants also showed associations across metabolic traits: the ADCY5 variant rs11720108-T was associated with glycated haemoglobin (β=−0.052, FDR=1.4×10−90), glucose (β=−0.050, FDR=3.0×10−71), and type 2 diabetes (OR=0.91, FDR=6.5×10−21), while the CRX variant rs2972516-T showed the strongest systemic association with serum vitamin D (β=0.058, FDR=8.0×10−76), alongside cholelithiasis (OR=0.89, FDR=3.3×10−14), IGF-1, and alkaline phosphatase.

Source: Foveal hypoplasia sentinel variants show extensive pleiotropy across ocular and systemic phenotypes. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were not compensated.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Genome-wide association and multi-omics functional screens reveal the genetic architecture of foveal development

Study design awaiting verification · medRxiv · 2026

Original publication title

Genome-wide association and multi-omics functional screens reveal the genetic architecture of foveal development

Callum Hunt; Manjiri Patil; Hammad Syed; Ha-Jun Yoon; Tingting Yang; Vanessa Rodwell; Zhanhan Tu; Gail DE Maconachie; Kayesha Coley; Alvin Lirio; Nick Shrine; Richard Packer; Mahmoud Fassad; Riddhi Shenoy; Natalie Allcock; Brandon Lim; Helen J Kuht; Girish Varma; Irem Karaer; Ranjit Injety; William Jakins; Reenette Savant; Rishi Sekhri; Michael Hisaund; Jinu Han; Seema Teli; Jun Wang; Zhen Zuo; Josh Whittingham; Gareth Douglas; Nicolas Sylvius; Pradeep C Vasudevan; Ala Moshiri; Jonathan H. Zippin; Brian P. Brooks; Lluis Montoliu; Irene Gottlob; Ko-Fan Chen; Takeshi Yoshimatsu; Martin D Tobin; William HJ Norton; Rui Chen; Chiara Batini; Mervyn G. Thomas

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Foveal hypoplasia causes visual impairment across congenital eye disorders, yet the genetic programmes governing foveal development remain poorly characterised and no tractable model exists for foveal disease. In the first genome-wide association study of foveal hypoplasia, we identified 42 sentinel variants mapping to 54 effector genes supported by ≥ 2 criteria from a variant-to-gene framework incorporating developmental multi-omics. Disruption of six effector genes using mutant lines and CRISPR knockouts in the zebrafish high acuity zone recapitulates structural, functional, and ultrastructural hallmarks of foveal hypoplasia, establishing the first vertebrate disease model.

Integration with human foetal single-cell and spatial transcriptomics reveals two temporal waves of effector gene expression and identifies Müller glia as critical mediators of foveal patterning. Phenome-wide analyses reveal foveal variants are pleiotropic with refractive, lenticular, and metabolic traits, connecting foveal development to anterior segment and systemic disease biology. These findings should inform mechanistic studies of macular disease.

Authors’ abstract

Foveal hypoplasia causes visual impairment across congenital eye disorders, yet the genetic programmes governing foveal development remain poorly characterised and no tractable model exists for foveal disease. In the first genome-wide association study of foveal hypoplasia, we identified 42 sentinel variants mapping to 54 effector genes supported by ≥ 2 criteria from a variant-to-gene framework incorporating developmental multi-omics. Disruption of six effector genes using mutant lines and CRISPR knockouts in the zebrafish high acuity zone recapitulates structural, functional, and ultrastructural hallmarks of foveal hypoplasia, establishing the first vertebrate disease model.

Integration with human foetal single-cell and spatial transcriptomics reveals two temporal waves of effector gene expression and identifies Müller glia as critical mediators of foveal patterning. Phenome-wide analyses reveal foveal variants are pleiotropic with refractive, lenticular, and metabolic traits, connecting foveal development to anterior segment and systemic disease biology. These findings should inform mechanistic studies of macular disease.

Publication and source details

Original title: Genome-wide association and multi-omics functional screens reveal the genetic architecture of foveal development

Callum Hunt; Manjiri Patil; Hammad Syed; Ha-Jun Yoon; Tingting Yang; Vanessa Rodwell; Zhanhan Tu; Gail DE Maconachie; Kayesha Coley; Alvin Lirio; Nick Shrine; Richard Packer; Mahmoud Fassad; Riddhi Shenoy; Natalie Allcock; Brandon Lim; Helen J Kuht; Girish Varma; Irem Karaer; Ranjit Injety; William Jakins; Reenette Savant; Rishi Sekhri; Michael Hisaund; Jinu Han; Seema Teli; Jun Wang; Zhen Zuo; Josh Whittingham; Gareth Douglas; Nicolas Sylvius; Pradeep C Vasudevan; Ala Moshiri; Jonathan H. Zippin; Brian P. Brooks; Lluis Montoliu; Irene Gottlob; Ko-Fan Chen; Takeshi Yoshimatsu; Martin D Tobin; William HJ Norton; Rui Chen; Chiara Batini; Mervyn G. Thomas

medRxiv · 2026

*

These authors contributed equally to this work

# Corresponding author, Fax: +44 (0)116 223 1996, mt350@le.ac.uk
https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T22:06:49.785807+00:00

DOI: 10.64898/2026.06.11.26355452 · PMC13278201